Treatment of Medial Epicondyle Fractures in Children and Adolescents

March 21, 2022 updated by: Petra Grahn, Helsinki University Central Hospital

Multi-center Comparative Study of Operative vs Nonoperative Treatment of Medial Epicondyle Fractures in Children and Adolescents

Cast immobilization in situ versus open reduction and internal fixation of displaced medial epicondyle fractures in children between 7 and 16 years old. A non-inferiority randomized controlled trial.

Study Overview

Detailed Description

This is a multicenter, controlled, prospective, randomized non-inferiority study comparing operative treatment to non-operative treatment of over 3 mm dislocated pediatric medial epicondyle fractures without joint incarceration or ulnar nerve dysfunction. A total of 120 patients will be randomized in 1:1 ratio to either operative or non-operative treatment. The study will have a parallel non-randomized patient preference arm. Non-operative treatment will be upper limb immobilization with long arm cast for 4 weeks. Operative treatment will be open reduction and internal fixation (ORIF). Data is collected at baseline and at each follow-up up to 2 years. Quick-DASH is used as primary outcome measure. Secondary outcomes are patient reported pain, differences in range of motion, PedsQL Life inventory questionnaire as well as Mayo elbow preformance score.

Study Type

Interventional

Enrollment (Anticipated)

120

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

      • Helsinki, Finland, 00029HUS
        • Recruiting
        • HUS New Childrens Hospital
        • Contact:
          • Petra Grahn, MD
          • Phone Number: +358 9 4711
        • Contact:
          • Matti Ahonen, MD
          • Phone Number: + 358 9 4711
      • Kuopio, Finland
        • Recruiting
        • Kuopio University Hospital
        • Contact:
          • Yrjänä Nietosvaara, MD
        • Contact:
          • Jenny Jalkanen, MD
      • Oulu, Finland
        • Not yet recruiting
        • Oulu University Hospital
        • Contact:
          • Juha-Jaakko Sinikumpu, MD
      • Tampere, Finland
        • Recruiting
        • Tampere University Hospital
        • Contact:
          • Anne Salonen, MD
      • Turku, Finland
        • Recruiting
        • Turku University Hospital
        • Contact:
          • Markus Lastikka, MD

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

7 years to 16 years (Child)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

- Over 2 mm displaced medial epicondyle fracture of humerus on primary AP or lateral X-ray

Exclusion Criteria:

  • Ulnar nerve dysfunction
  • Pathological fracture
  • Open fracture
  • Systemic bone disease
  • Concomitant fracture or injury of the same upper limb requiring operative intervention
  • Other disease preventing participation in full follow-up regime or range of motion exercises

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Double

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: RCT operative
Procedure of preference is open reduction and internal fixation (ORIF) with cannulated non-resolvable 4.0mm screw with or without washer. If the fracture fragment is too small or fragmented for screw fixation 1.6mm - 1.8mm Kirshner-wires and/or bone anchor are used. Long arm cast for 4 weeks.
Surgery
Active Comparator: RCT Non-operative
Non-operative treatment means upper limb immobilization with forearm in neutral pro-supination with a long arm cast for 4 weeks.
cast immobilization
Other: Patient preference operative
Procedure of preference is open reduction and internal fixation (ORIF) with cannulated non-resolvable 4.0mm screw with or without washer. If the fracture fragment is too small or fragmented for screw fixation 1.6mm - 1.8mm Kirshner-wires and/or bone anchor are used. Long arm cast for 4 weeks.
Surgery
Other: Patient preference non-operative
Non-operative treatment means upper limb immobilization with forearm in neutral pro-supination with a long arm cast for 4 weeks.
cast immobilization

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Quick Disabilities of the Arm, Shoulder and Hand score questionnaire(QuickDASH)
Time Frame: 12 months
Minimum value is 0 and maximum 100. Higher value indicates worse function. Statistically significant difference in QuickDASH score is 6.8 (18) at 12 months FU.
12 months

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Range of Motion (ROM) degrees difference of the elbow as compared to uninjured arm
Time Frame: 12 months
Difference in active ROM in comparison to uninjured arm. Maximum value is 160 degrees minimum 0. Lower value indicates better outcome.
12 months
Measurement Model for the Pediatric Quality of Life Inventory questionnaire (PedsQL)
Time Frame: 12 months
Minimum score is 0 and maximum 100. Higher score indicates better health related quality of life.
12 months
Measurement Model for the Pediatric Quality of Life Inventory Pediatric Pain Questionaire (PEDS QL PPQ)
Time Frame: 12 months
Minimum score 0 maximum 10. Higher value indicates higher pain intensity.
12 months
Cosmetic Visual Analoque Scale (CVAS)
Time Frame: 12 months
Minimum score 0 maximum 100. Higher value indicates better cosmetic appearance
12 months
Mayo Elbow Performance Score (MEPS)
Time Frame: 12 months
Minimum score 0 maximum 100. Higher value indicates better performance.
12 months
Need for additional procedures (number)
Time Frame: 12 months
Minimum value 0, no maximum value. Lower value indicates better outcome.
12 months
Grip strength (kg) with hand held dynamometer (jamar)
Time Frame: 12 months
compared to standard for age kg/age
12 months
Sensation and cold intolerance
Time Frame: 12 months
semmes-weinstein monofilaments scored as normal or abnormal
12 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Petra Grahn, MD, Helsinki University Hospital, New Childrens Hospital

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Helpful Links

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

August 30, 2019

Primary Completion (Anticipated)

December 31, 2023

Study Completion (Anticipated)

December 31, 2025

Study Registration Dates

First Submitted

August 22, 2020

First Submitted That Met QC Criteria

August 26, 2020

First Posted (Actual)

August 28, 2020

Study Record Updates

Last Update Posted (Actual)

March 24, 2022

Last Update Submitted That Met QC Criteria

March 21, 2022

Last Verified

March 1, 2022

More Information

Terms related to this study

Other Study ID Numbers

  • HUS/1443/2019

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

YES

IPD Plan Description

Data will be available upon request. Any requests should be sent to the principal investigator.

IPD Sharing Time Frame

upon request. Most of the above published in BMJ Open.

IPD Sharing Access Criteria

Please see BMJ open

IPD Sharing Supporting Information Type

  • STUDY_PROTOCOL
  • SAP
  • ICF
  • ANALYTIC_CODE
  • CSR

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Medial Epicondyle Fracture of the Humerus

Clinical Trials on Operative treatment

3
Subscribe